Higher circulating estradiol is associated in the general population with a pre-menopausal breast cancer risk, and BRCA2 carriers with breast cancer do have higher estradiol levels in the early follicular phase, but a similar association with circulating progesterone is not seen. This evidence concerns the gene BRCA2 and breast carcinoma.